Neoadjuvant Tremelimumab and Durvalumab With Gem/Cis in Intrahepatic Cholangiocarcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Gemcitabine
Related studies linked through entity extraction aliases.
Thalidomide to Chemotherapy Related Nausea and Vomiting in Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Perioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract Cancers
- Status
- RECRUITING
- Phase
- PHASE2
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Phase IB Study to Determine the Safety and Tolerability of Canakinumab and Tislelizumab in Combination With Nab-Paclitaxel and Gemcitabine in the Neo-adjuvant Treatment of Patients With Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Efficacy of Plasmid Elenagen in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Cadonilimab With Chemotherapy in Treating Advanced Biliary Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Treating Muscle-invasive Bladder Cancer With A Non-surgical Method Consisting of Anti-PD-1 Therapy and Chemoradiation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A LM-302 Combination With Other Anti-Tumor Therapies Phase ll Study
- Status
- RECRUITING
- Phase
- PHASE2
Study of an Anti-HER3 Antibody, HMBD-001, With or Without Chemotherapy in Patients With Solid Tumors Harboring an NRG1 Fusion or HER3 Mutation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Canagliflozin With Gemcitabine in Pancreatic Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Cadonilimab in the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
A Study to Evaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors; Urothelial Carcinoma Substudy in Association With RO7496353 Study GO44010
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
GEM+Nab-Paclitaxel Plus Losartan Followed by Stereotactic Radiotherapy for Locally Advanced Pancreatic Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Gemcitabine and Camrelizumab Plus Apatinib Versus Cisplatin in First-line Treatment of RM-NPC
- Status
- RECRUITING
- Phase
- PHASE3